Meredith M J, Williams G M
J Biol Chem. 1986 Apr 15;261(11):4986-92.
The nontumorigenic ARL-15C1 and tumorigenic gamma-glutamyl transpeptidase-containing ARL-16T2 cell lines were found to contain approximately equal amounts of glutathione, cysteine, and cystine, 65.6, 3.5, and 5 nmol/mg of protein for ARL-16C1, and 61.5, 3, and 3 nmol/mg of protein for ARL-16T2, respectively. The half-life for glutathione in these cell lines was 3.2 and 3.8 h in the ARL-15C1 and 16T2, respectively. In ARL-15C1 cells, the cysteine half-life was 0.2 h and that of cystine 2.0 h compared to 2.0 h and 0.5 h, respectively, in the ARL-16T2. The turnover of glutathione in the ARL-15C1 could be accounted for by efflux into the medium whereas only 10% of the glutathione expected from ARL-16T2 cells appeared in the medium. The ARL-16T2 cells appear to support glutathione synthesis by conservation and recycling of cysteine residues. Inhibition of gamma-glutamyl transpeptidase by AT-125 (acivicin) caused extensive loss of intracellular glutathione from ARL-16T2 cells but produced no effect on GSH levels in ARL-15C1 cells. No metabolism of medium glutathione by gamma-glutamyl transpeptidase was detected, independent of AT-125 treatment. AT-125 treatment caused a transient increase in intracellular GSH in the ARL-16T2 but not the ARL-15C1, further suggesting that the enzyme catalyzes intracellular GSH recycling to supply cysteine for cellular functions in the tumorigenic ARL-16T2 cell line. Transport of cysteine, cystine, and methionine was not altered by AT-125 treatment. These data are consistent with an intracellular orientation of gamma-glutamyl transpeptidase in this cell line and not participation in extracellular processes.
非致瘤性的ARL-15C1细胞系和含γ-谷氨酰转肽酶的致瘤性ARL-16T2细胞系被发现含有大致等量的谷胱甘肽、半胱氨酸和胱氨酸,ARL-16C1细胞系中分别为65.6、3.5和5 nmol/mg蛋白质,ARL-16T2细胞系中分别为61.5、3和3 nmol/mg蛋白质。这些细胞系中谷胱甘肽的半衰期在ARL-15C1细胞系中为3.2小时,在ARL-16T2细胞系中为3.8小时。在ARL-15C1细胞中,半胱氨酸的半衰期为0.2小时,胱氨酸的半衰期为2.0小时,而在ARL-16T2细胞中,半胱氨酸和胱氨酸的半衰期分别为2.0小时和0.5小时。ARL-15C1细胞中谷胱甘肽的周转可通过其外流到培养基中来解释,而ARL-16T2细胞预期的谷胱甘肽中只有10%出现在培养基中。ARL-16T2细胞似乎通过半胱氨酸残基的保存和再循环来支持谷胱甘肽的合成。AT-125(阿西维辛)对γ-谷氨酰转肽酶的抑制导致ARL-16T2细胞内谷胱甘肽大量损失,但对ARL-15C1细胞中的谷胱甘肽水平没有影响。未检测到γ-谷氨酰转肽酶对培养基中谷胱甘肽的代谢,与AT-125处理无关。AT-125处理导致ARL-16T2细胞内谷胱甘肽短暂增加,但ARL-15C1细胞未出现这种情况,这进一步表明该酶催化细胞内谷胱甘肽的再循环,为致瘤性ARL-16T2细胞系中的细胞功能提供半胱氨酸。AT-125处理未改变半胱氨酸、胱氨酸和蛋氨酸 的转运。这些数据与该细胞系中γ-谷氨酰转肽酶的细胞内定位一致,且其不参与细胞外过程。